Baebies, Inc., based in Durham, US, is dedicated to delivering early disease detection and comprehensive diagnostics through innovative screening and testing platforms powered by digital microfluidics. The company focuses on newborn screening and pediatric testing products, aiming to ensure that every child, regardless of socio-economic status or geography, has a healthy start. Baebies serves a global market, providing high-throughput solutions for early and accurate disease detection.
Baebies has made significant strides in the medical diagnostics field, leveraging cutting-edge technology to improve health outcomes for newborns and children worldwide. Their commitment to innovation and accessibility has positioned them as a key player in pediatric healthcare. The company's impact is evident in its widespread adoption and the positive health outcomes facilitated by its products.
